Skip to main content
TipRanks
Go Ultimate75% OFF

VitaNova Life Sciences (VNOV) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

VitaNova Life Sciences has a market cap or net worth of $23.51M. The enterprise value is $39.00T.

Market Cap
$23.51M
Enterprise Value
$39.00T

Share Statistics

VitaNova Life Sciences has 8,337,454 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
8,337,454
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

VitaNova Life Sciences’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is 44.72%.

Return on Equity (ROE)
0.45
Return on Assets (ROA)
0.38
Return on Invested Capital (ROIC)
44.72%
Return on Capital Employed (ROCE)
0.63
Revenue Per Employee
380.30K
Profits Per Employee
121.54K
Employee Count
7
Asset Turnover
1.18
Inventory Turnover
24.55

Valuation Ratios

The current PE Ratio of VitaNova Life Sciences is 46.67. VitaNova Life Sciences’s PEG ratio is -7.76.

PE Ratio
46.67
PS Ratio
14.42
PB Ratio
21.21
Price to FCF
34.58
Price to Operating Cash Flow
34.58
PEG Ratio
-7.76

Income Statement

In the last 12 months, VitaNova Life Sciences had revenue of 2.66M and earned 850.75K in profits. Earnings per share was 0.10.

Revenue
2.66M
Gross Profit
1.58M
Operating Income
1.21M
Pretax Income
1.20M
Net Income
850.75K
EBITDA
1.21M
Earnings Per Share (EPS)
0.10

Cash Flow

In the last 12 months, operating cash flow was 1.16M and capital expenditures 0, giving a free cash flow of 1.16M billion.

Operating Cash Flow
1.16M
Free Cash Flow
1.16M
Free Cash Flow per Share
0.14

Dividends & Yields

VitaNova Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
2.89%
Earnings Yield
2.14%

Stock Price Statistics

Beta
-5.65
52-Week Price Change
-41.61%
50-Day Moving Average
2.83
200-Day Moving Average
2.81
Relative Strength Index (RSI)
48.27
Average Volume (3m)
280

Financial Position

VitaNova Life Sciences as a current ratio of 6.49, with Debt / Equity ratio of 0.00%

Current Ratio
6.49
Quick Ratio
6.36
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.65
Interest Coverage Ratio
268.16

Taxes

In the past 12 months, VitaNova Life Sciences has paid 353.56K in taxes.

Income Tax
353.56K
Effective Tax Rate
0.29

Enterprise Valuation

VitaNova Life Sciences EV to EBITDA ratio is 31.00, with an EV/FCF ratio of 33.49.

EV to Sales
13.97
EV to EBITDA
31.00
EV to Free Cash Flow
33.49
EV to Operating Cash Flow
33.49

Balance Sheet

VitaNova Life Sciences has $1.26M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.26M billion.

Cash & Marketable Securities
$1.26M
Total Debt
$0.00
Net Cash
$1.26M
Net Cash Per Share
$0.15
Tangible Book Value Per Share
$0.08

Margins

Gross margin is 60.03%, with operating margin of 46.29%, and net profit margin of 30.90%.

Gross Margin
60.03%
Operating Margin
46.29%
Pretax Margin
44.97%
Net Profit Margin
30.90%
EBITDA Margin
45.06%
EBIT Margin
45.06%

Analyst Forecast

The average price target for VitaNova Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
22.04%
EPS Growth Forecast
-113.29%